Share class: Dr. Reddy's Laboratories Limited

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 834,569,935 587,017,042 ( 70.34 %) 1,448,955 ( 0.1736 %) 70.34 %

Major shareholders: Dr. Reddy's Laboratories Limited

NameEquities%Valuation
11.51 %
96,095,920 11.51 % 1 359 M ₹
9.605 %
80,161,330 9.605 % 1 134 M ₹
3.309 %
27,618,385 3.309 % 391 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
1.945 %
16,230,903 1.945 % 230 M ₹
PPFAS Asset Management Private Ltd.
1.646 %
13,735,036 1.646 % 194 M ₹
1.524 %
12,717,090 1.524 % 180 M ₹
SBI Funds Management Ltd.
1.44 %
12,020,477 1.44 % 170 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
1.098 %
9,167,121 1.098 % 130 M ₹
HDFC Life Insurance Co. Ltd. (Investment Portfolio)
1.025 %
8,553,695 1.025 % 121 M ₹
SBI Life Insurance Co. Ltd. (Investment Portfolio)
0.7582 %
6,327,563 0.7582 % 89 M ₹
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
NameEquities%Valuation
Robeco Alternative Investments
1.568 %
13,084,506 1.568 % 184 M ₹
Aperio Group LLC
1.302 %
10,869,515 1.302 % 153 M ₹
RBC Dominion Securities, Inc.
1.218 %
10,162,215 1.218 % 143 M ₹
Renaissance Technologies LLC
1.052 %
8,782,628 1.052 % 123 M ₹
Aikya Investment Management Ltd.
0.8046 %
6,715,007 0.8046 % 94 M ₹
Morgan Stanley Capital Services LLC
0.7575 %
6,322,154 0.7575 % 89 M ₹
JPMorgan Investment Management, Inc.
0.7222 %
6,027,710 0.7222 % 85 M ₹
Vanguard Fiduciary Trust Co.
0.6139 %
5,123,709 0.6139 % 72 M ₹
DFA Australia Ltd.
0.5467 %
4,563,072 0.5467 % 64 M ₹
0.4982 %
4,158,331 0.4982 % 58 M ₹
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Individuals26.02%
Institutional21.63%
Other3.59%
State Street Corp.0.5%
SEI Investments Co.0.03%
Zurich Insurance Group AG0.02%
Unknown48.2%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
26.03%
India
11.79%
United States
8.13%
Netherlands
1.58%
Canada
1.31%
United Kingdom
1.18%
Australia
0.56%
Ireland
0.21%
Sweden
0.18%
Hong Kong
0.15%
Norway
0.11%
Germany
0.11%
Switzerland
0.11%
Luxembourg
0.06%
Japan
0.06%
Austria
0.05%
Singapore
0.05%
Denmark
0.04%
France
0.03%
Belgium
0.01%
Finland
0.01%
Slovenia
0.01%
Israel
0.01%

Based on 1000 largest holdings

Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,811
More about the company